Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase

Journal of Bacteriology

Volumn 187, Issue 22, 2005, Pages 7561-7568

  Silo Suh, Laura ^a   Suh, Sang Jin ^a   Phibbs, Paul V ^b   Ohman, Dennis E ^c,d  

^a AUBURN UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CATABOLITE REPRESSION CONTROL PROTEIN; EXOPOLYSACCHARIDE; GENE PRODUCT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PROTEIN SIGMA22; REGULATOR PROTEIN; SUCCINIC ACID; UNCLASSIFIED DRUG;

ADAPTATION; ALGT GENE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BACTERIUM MUTANT; CARBON METABOLISM; CATABOLISM; CATABOLITE REPRESSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM; ZWF GENE;

ADAPTATION, PHYSIOLOGICAL; ALGINATES; AMIDOHYDROLASES; BACTERIAL PROTEINS; BETA-GALACTOSIDASE; CYSTIC FIBROSIS; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REPORTER; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; LUNG; MUTATION; PSEUDOMONAS AERUGINOSA; REPRESSOR PROTEINS; SIGMA FACTOR; SPUTUM;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 27744562615     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.187.22.7561-7568.2005     Document Type: Article

References (49)

1. Chitnis, C. E., and D. E. Ohman. 1993. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure. Mol. Microbiol. 8:583-590.
2. Collier, D. N., P. W. Hager, and P. V. Phibbs, Jr. 1996. Catabolite repression control in the Pseudomonads. Res. Microbiol. 147:551-561.
3. Cox, C. D. 1986. Role of pyocyanin in the acquisition of iron from transferrin. Infect. Immun. 52:263-270.
4. Dacheux, D., I. Attree, and B. Toussaint. 2001. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect. Immun. 69:538-542.
5. Davis, R. W., D. Holstein, and J. R. Roth. 1980. Advanced bacterial genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N. Y.
6. Gallant, C. V., T. L. Raivio, J. C. Olson, D. E. Woods, and D. G. Storey. 2000. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity. Microbiology 146:1891-1899.
7. Govan, J. R. W., and G. S. Harris. 1986. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol. Sci. 3:302-308.
8. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
9. Hancock, R. E. W., L. M. Mutharia, L. Chan, R. P. Darveau, D. P. Speert, and G. B. Pier. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypeable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42:170-177.
10. Hatch, R. A., and N. L. Schiller. 1998. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:974-977.
11. Holloway, B. W., V. Krishnapillai, and A. F. Morgan. 1979. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102.
12. Hylemon, P. B., and P. V. Phibbs, Jr. 1972. Independent regulation of hexose catabolizing enzymes and glucose transport activity in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 48:1041-1048.
13. Knutson, C. A., and A. Jeanes. 1968. A new modification of the carbazole analysis: application to heteropolysaccharides. Anal. Biochem. 24:470-481,
14. Lessie, T. G., and P. V. Phibbs, Jr. 1984. Alternative pathways of carbohydrate utilization in pseudomonads. Annu. Rev. Microbiol. 38:359-388.
15. Li, Z., M. R. Kosorok, P. M. Farrell, A. Laxova, S. E. West, C. G. Green, J. Collins, M. J. Rock, and M. L. Splaingard. 2005. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293:581-588.
16. Luzar, M. A., and T. C. Montie. 1985. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa. Infect. Immun. 50:572-576.
17. Luzar, M. A., M. J. Thomassen, and T. C. Montie. 1985. Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect. Immun. 50:577-582.
18. Ma, J. F., P. W. Hager, M. L. Howell, P. V. Phibbs, and D. J. Hassett. 1998. Cloning and characterization of the Pseudomonas aeruginosa zwf gene encoding glucose-6-phosphate dehydrogenase, an enzyme important in resistance to methyl viologen (paraquat). J. Bacteriol. 180:1741-1749.
19. MacGregor, C. H., S. K. Arora, P. W. Hager, M. B. Dail, and P. V. Phibbs, Jr. 1996. The nucleotide sequence of the Pseudomonas aeruginosa pyrE-crc-rph region and the purification of the crc gene product. J. Bacteriol. 178: 5627-5635.
20. MacGregor, C. H., J. A. Wolff, S. K. Arora, and P. V. Phibbs, Jr. 1991. Cloning of a catabolite repression control (crc) gene from Pseudomonas aeruginosa, expression of the gene in Escherichia coli, and identification of the gene product in Pseudomonas aeruginosa. J. Bacteriol. 173:7204-7212.
21. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
22. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
23. Martin, D. W., M. J. Schurr, M. H. Mudd, J. R. W. Govan, B. W. Holloway, and V. Deretic. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 90: 8377-8381.
24. Mathee, K., O. Ciofu, C. K. Sternberg, P. Lindum, J. Campbell, P. Jensen, A. Johnsen, M. Givskov, D. Ohman, S. Molin, N. Høiby, and A. Kharazmi. 1999. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145:1349-1357.
25. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
26. Mouton, J. W., J. G. den Hollander, and A. M. Horrevorts. 1993. Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J. Antimicrob. Chemother. 31:919-926.
27. Narbad, A., N. J. Russell, and P. Gacesa. 1988. Radiolabelling patterns in alginate of Pseudomonas aeruginosa synthesized from specifically-labelled 14C-monosaccharide precursors. Microbios 54:171-179.
28. Ohman, D. E., and A. M. Chakrabarty. 1981. Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate. Infect. Immun. 33:142-148.
29. Oliver, A., R. Canton, P. Campo, F. Baquero, and J. Blazquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254.
30. Oliver, A. M., and D. M. Weir. 1985. The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization. Clin. Exp. Immunol. 59:190-196.
31. O'Toole, G. A., K. A. Gibbs, P. W. Hager, P. V. Phibbs, Jr., and R. Kolter. 2000. The global carbon metabolism regulator Crc is a component of a signal transduction pathway required for biofilm development by Pseudomonas aeruginosa. J. Bacteriol. 182:425-431.
32. Pedersen, S. S., A. Kharazmi, F. Espersen, and N. Hoiby. 1990. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect. Immun. 58:3363-3368.
33. Rahme, L. G., E. J. Stevens, S. F. Wolfort, J. Shao, R. G. Tompkins, and F. M. Ausubel. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902,
34. Ruiz-Manzano, A., L. Yuste, and F. Rojo. 2005. Levels and activity of the Pseudomonas putida global regulatory protein Crc vary according to growth conditions. J. Bacteriol. 187:3678-3686.
35. Schweizer, H. P. 1993. Small broad-host-range gentamicin resistance gene cassettes for site-specific insertion and deletion mutagenesis. BioTechniques 15:831-833.
36. Schweizer, H. P., and T. T. Hoang. 1995. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158:15-22.
37. Silo-Sun, L., S. J. Sun, P. A. Sokol, and D. E. Ohman. 2002. A simple alfalfa seedling infection model for Pseudomonas aeruginosa strains associated with cystic fibrosis shows AlgT (sigma-22) and RhIR contribute to pathogenesis. Proc. Natl. Acad. Sci. USA. 99:15699-15704.
38. Simpson, J. A., S. E. Smith, and R. T. Dean. 1989. Scavenging by alginate of free radicals released by macrophages. Free Radic. Biol. Med. 6:347-353.
39. Spencer, D. H., A. Kas, E. E. Smith, C. K. Raymond, E. H. Sims, M. Hastings, J. L. Burns, R. Kaul, and M. V. Olson. 2003. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 185:1316-1325.
40. Suh, S. J., L. Silo-Suh, and D. E. Ohman. 2004. Development of tools for the genetic manipulation of Pseudomonas aeruginosa. J Microbiol. Methods 58: 203-212.
41. Suh, S. J., L. Silo-Suh, D. E. Woods, D. J. Hassett, S. E. West, and D. E. Ohman. 1999. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J. Bacteriol. 181:3890-3897.
42. Temple, L., S. M. Cuskey, R. E. Perkins, R. C. Bass, N. M. Morales, G. E. Christie, R. H. Olsen, and P. V. Phibbs, Jr. 1990. Analysis of cloned structural and regulatory genes for carbohydrate utilization in Pseudomonas aeruginosa PAO. J. Bacteriol. 172:6396-6402.
43. Thomas, S. R., A. Ray, M. E. Hodson, and T. L. Pitt. 2000. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55:795-797.
44. van Heeckeren, A. M., and M. D. Schluchter. 2002. Murine models of chronic Pseudomonas aeruginosa lung infection. Lab. Anim. 36:291-312.
45. Warrens, A. N., M. D. Jones, and R. I. Lechler. 1997. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 186: 29-35.
46. Wolff, J. A., C. H. MacGregor, R. C. Eisenberg, and P. V. Phibbs, Jr. 1991. Isolation and characterization of catabolite repression control mutants of Pseudomonas aeruginosa PAO. J. Bacteriol. 173:4700-4706.
47. Woods, D. E., and L. E. Bryan. 1985. Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J. Infect. Dis. 151:581-588.
48. Woods, D. E., M. S. Schaffer, H. R. Rabin, G. D. Campbell, and P. A. Sokol. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 24:260-264.
49. Wozniak, D. J., and D. E. Ohman. 1994. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT, J. Bacteriol. 176: 6007-6014.